Wipro manages operations for global pharma and biopharma companies to transform end-to-end pharmacovigilance (PV) drug safety service requirements. This includes Individual Case Safety Reports (ICSR), Periodic Safety Reports, Risk Management and Signal Detection. We are leaders in the industry with 15 years of experience, over 350,000 annual cases processed, more than 400 PV associates (28% with more than five years of experience), and experience across more than 15 therapeutic areas, as well as over 900 product categories.
Typical improvements for Wipro clients :
- Around 96% case processing quality
- 40% efficiency improvement
- 3% productivity gains year-on-year
- Around 98% case regulatory submission compliance